TrialBMC medicine2024

Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.

Huayi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.